FDA
-
-
-
-
-
-
-
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
-
-
-
-
-
-
-
Lilly's retatrutide meets goals in two Phase 3 obesity trials
-
-
-
-
-
-
-
Teva lawsuit against Eli Lilly over Forteo revived by appeals court
-
-
-
-
-
-
-
Sandoz submits generic obesity drug applications to FDA
-
-
-
-
-
-
-
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
-
-
-
-
-
-
-
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
-
-
-
-
-
-
-
Hanmi Signs Licensing Deal with Lilly for sonefpeglutide
-
330,173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

